Overview

Pitavastatin on Carotid Intima-media Thickness

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
This study is aimed to analyze the effects of aggressive and conventional lipid lowering therapy with Pravastatin on carotid intima-media thickness (IMT) in patients with hyperlipidemia and abnormal thickening of IMT.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Kyoto Prefectural University of Medicine
Treatments:
Pitavastatin
Criteria
Inclusion Criteria:

- Diagnosed as having hyperlipidemia

- LDL-C at the time of enrollment is no less than 100

- Common carotid IMT is 1.1 mm and over

Exclusion Criteria:

- Received or planned to receive intervention on carotid arteries during the study
period

- Overt liver dysfunction (ALT; 100 IU/L and over)

- Overt renal dysfunction (serum creatinine; 2.0 mg/dL and over)

- Receiving Cyclosporin

- Hyperreactive to Pitavastatin

- During pregnancy or lactation